456 related articles for article (PubMed ID: 11279780)
1. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable).
Rowell NP; Williams CJ
Cochrane Database Syst Rev; 2001; (1):CD002935. PubMed ID: 11279780
[TBL] [Abstract][Full Text] [Related]
2. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable).
Rowell NP; Williams CJ
Cochrane Database Syst Rev; 2001; (2):CD002935. PubMed ID: 11406051
[TBL] [Abstract][Full Text] [Related]
3. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review.
Rowell NP; Williams CJ
Thorax; 2001 Aug; 56(8):628-38. PubMed ID: 11462066
[TBL] [Abstract][Full Text] [Related]
4. Palliative radiotherapy regimens for patients with thoracic symptoms from non-small cell lung cancer.
Stevens R; Macbeth F; Toy E; Coles B; Lester JF
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD002143. PubMed ID: 25586198
[TBL] [Abstract][Full Text] [Related]
5. A systematic overview of radiation therapy effects in non-small cell lung cancer.
Sirzén F; Kjellén E; Sörenson S; Cavallin-Ståhl E
Acta Oncol; 2003; 42(5-6):493-515. PubMed ID: 14596509
[TBL] [Abstract][Full Text] [Related]
6. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
Okawara G; Rusthoven J; Newman T; Findlay B; Evans W
Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of accelerated radiotherapy for patients with inoperable non-small cell lung cancer (NSCLC) and borderline prognostic factors without distant metastasis: a retrospective review.
Nguyen LN; Komaki R; Allen P; Schea RA; Milas L
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1053-6. PubMed ID: 10421538
[TBL] [Abstract][Full Text] [Related]
8. Radiation therapy of stage I and II non-small cell lung cancer (NSCLC).
Zierhut D; Bettscheider C; Schubert K; van Kampen M; Wannenmacher M
Lung Cancer; 2001 Dec; 34 Suppl 3():S39-43. PubMed ID: 11740992
[TBL] [Abstract][Full Text] [Related]
9. WITHDRAWN: Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable).
Rowell NP; Williams C
Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD002935. PubMed ID: 25756660
[TBL] [Abstract][Full Text] [Related]
10. Comparison of curative and palliative radiotherapy efficacy in unresectable advanced non-small cell lung cancer patients with or without metastasis.
Unlu I; Diniz G; Komurcuoglu B; Gayaf M; Gokce T; Karadogan I; Akcay C
Saudi Med J; 2006 Jun; 27(6):849-53. PubMed ID: 16758049
[TBL] [Abstract][Full Text] [Related]
11. Concurrent chemoradiotherapy in non-small cell lung cancer.
Rowell NP; O'rourke NP
Cochrane Database Syst Rev; 2004 Oct; (4):CD002140. PubMed ID: 15495029
[TBL] [Abstract][Full Text] [Related]
12. Radical radiotherapy in stage I non-small cell lung cancer (NSCLC)--Singapore National Cancer Centre experience.
Low JSh; Koh WY; Yap SP; Fong KW
Ann Acad Med Singap; 2007 Sep; 36(9):778-83. PubMed ID: 17925989
[TBL] [Abstract][Full Text] [Related]
13. Population-based analysis of curative therapies in stage II non-small cell lung cancer: the role of radiotherapy in medically inoperable patients.
Moore S; Leung B; Wu J; Ho C
Radiat Oncol; 2020 Jan; 15(1):23. PubMed ID: 32000829
[TBL] [Abstract][Full Text] [Related]
14. Palliative radiotherapy regimens for non-small cell lung cancer.
Lester JF; Macbeth FR; Toy E; Coles B
Cochrane Database Syst Rev; 2006 Oct; (4):CD002143. PubMed ID: 17054152
[TBL] [Abstract][Full Text] [Related]
15. SOCCAR: A randomised phase II trial comparing sequential versus concurrent chemotherapy and radical hypofractionated radiotherapy in patients with inoperable stage III Non-Small Cell Lung Cancer and good performance status.
Maguire J; Khan I; McMenemin R; O'Rourke N; McNee S; Kelly V; Peedell C; Snee M
Eur J Cancer; 2014 Nov; 50(17):2939-49. PubMed ID: 25304298
[TBL] [Abstract][Full Text] [Related]
16. A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer.
Liao Z; Komaki R; Milas L; Yuan C; Kies M; Chang JY; Jeter M; Guerrero T; Blumenschien G; Smith CM; Fossella F; Brown B; Cox JD
Clin Cancer Res; 2005 May; 11(9):3342-8. PubMed ID: 15867233
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy alone in technically operable, medically inoperable, early-stage (I/II) non-small-cell lung cancer.
Jeremic B; Classen J; Bamberg M
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):119-130. PubMed ID: 12182981
[TBL] [Abstract][Full Text] [Related]
18. Concurrent low-dose cisplatin and thoracic radiotherapy in patients with inoperable stage III non-small cell lung cancer: a phase II trial with special reference to the hemoglobin level as prognostic parameter.
Pradier O; Lederer K; Hille A; Weiss E; Christiansen H; Schmidberger H; Hess CF
J Cancer Res Clin Oncol; 2005 Apr; 131(4):261-9. PubMed ID: 15616830
[TBL] [Abstract][Full Text] [Related]
19. [Assessment the efficacy of postoperative radiotherapy in the patients with non-small cell lung cancer. Retrospective study].
Chmielewska E; Jodkiewicz Z; Karwański M
Pneumonol Alergol Pol; 2012; 80(2):109-19. PubMed ID: 22370979
[TBL] [Abstract][Full Text] [Related]
20. A new index comparable to BED for evaluating the biological efficacy of hypofractionated radiotherapy schemes on early stage non-small cell lung cancer: analysis of data from the literature.
Kong C; Guo WJ; Zha WW; Zhu XZ; Huang SF; Zhang YW; Xu JH; He X
Lung Cancer; 2014 Apr; 84(1):7-12. PubMed ID: 24548340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
